Jane Street’s Greenwich LifeSciences GLSI Stock Holding History

Jane Street’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,677	Closed	-$203K	–	12087
2025 Q4	$203K	Buy	+9,677	New	+$102K	﹤0.01%	9690
2024 Q2	–	Sell	-20,642	Closed	-$412K	–	9674
2024 Q1	$412K	Buy	20,642 +6,637	+47%	+$81.9K	﹤0.01%	7039
2023 Q4	$147K	Buy	+14,005	New	+$140K	﹤0.01%	8404
2023 Q2	–	Sell	-18,510	Closed	-$255K	–	9003
2023 Q1	$255K	Buy	+18,510	New	+$294K	﹤0.01%	7451
2022 Q1	–	Sell	-8,570	Closed	-$209K	–	10554
2021 Q4	$209K	Buy	8,570 +1,679	+24%	+$56.2K	﹤0.01%	8749
2021 Q3	$269K	Buy	6,891 +1,388	+25%	+$58K	﹤0.01%	8390
2021 Q2	$247K	Buy	+5,503	New	+$208K	﹤0.01%	8485

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Jane Street's GLSI Position: Q1 2026 in Review

Jane Street sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 9,677 shares — an estimated $203K sold.

Jane Street first reported a position in GLSI in Q2 2021 and held it in 7 quarters. The position peaked at $412K in Q1 2024. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Jane Street reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 9,677 Greenwich LifeSciences shares in Q1 2026, an estimated $203K.
Jane Street first reported a position in Greenwich LifeSciences in Q2 2021 and held it in 7 quarters.
Jane Street's Greenwich LifeSciences position peaked at $412K in Q1 2024.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.